Legal13 Jul 2026, 09:00 pm
Gujarat Themis Biosyn Settles Arbitration with Optimus Drugs
AI Summary
Gujarat Themis Biosyn Ltd has announced the amicable resolution of a commercial dispute with Optimus Drugs Private Limited, which was previously under arbitration. The company had initiated arbitration proceedings on June 26, 2026, against Optimus Drugs. Following a mutual settlement, the arbitration will be disposed of. Importantly, the settlement means Gujarat Themis Biosyn will not incur any penalty, and there will be no material financial impact on the company. This update is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Arbitration with Optimus Drugs amicably resolved.
- No penalty to be paid by Gujarat Themis Biosyn.
- No material financial impact expected from settlement.
- Dispute was over commercial differences.
- Update complies with SEBI LODR Regulations.
Price Impact
More from GUJTHEM